StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Processa Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Processa Pharmaceuticals's operating cash flow for the twelve months ending Dec 31, 2025 was -$11.39M. For fiscal 2025 it was -$11.39M. The highest annual figure on record is -$871.91K in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.39M–
FY2024Dec 31, 2024-$11.25M–
FY2023Dec 31, 2023-$8.06M–
FY2022Dec 31, 2022-$9.61M–
FY2021Dec 31, 2021-$8.72M–
FY2020Dec 31, 2020-$3.14M–
FY2019Dec 31, 2019-$2.75M–
FY2018Dec 31, 2018-$3.71M–
FY2017Dec 31, 2017-$1.65M–
FY2016Dec 31, 2016-$2.16M–
FY2015Dec 31, 2015-$871.91K–
FY2014Dec 31, 2014-$2.69M–
FY2013Dec 31, 2013-$2.54M–
FY2012Dec 31, 2012-$1.89M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.00M–
Q1 FY2026Mar 31, 2026-$3.59M–
Q4 FY2025Dec 31, 2025-$2.90M–
Q1 FY2025Mar 31, 2025-$2.73M–
Q4 FY2024Dec 31, 2024-$2.25M–
Q3 FY2024Sep 30, 2024-$3.60M–
Q2 FY2024Jun 30, 2024-$3.35M–
Q1 FY2024Mar 31, 2024-$2.05M–
Q4 FY2023Dec 31, 2023-$2.12M–
Q3 FY2023Sep 30, 2023-$1.76M–
Q2 FY2023Jun 30, 2023-$2.06M–
Q1 FY2023Mar 31, 2023-$2.11M–
Q4 FY2022Dec 31, 2022-$2.50M–
Q3 FY2022Sep 30, 2022-$2.97M–
Q2 FY2022Jun 30, 2022-$2.33M–
Q1 FY2022Mar 31, 2022-$1.80M–
Q4 FY2021Dec 31, 2021-$2.73M–
Q3 FY2021Sep 30, 2021-$1.55M-5419.7%
Q2 FY2021Jun 30, 2021-$2.19M–
Q1 FY2021Mar 31, 2021-$2.24M–
Q4 FY2020Dec 31, 2020-$2.28M–
Q3 FY2020Sep 30, 2020$29.19K–
Q2 FY2020Jun 30, 2020-$350.58K–
Q1 FY2020Mar 31, 2020-$546.45K–
Q4 FY2019Dec 31, 2019-$613.49K–
Q3 FY2019Sep 30, 2019-$721.76K–
Q2 FY2019Jun 30, 2019-$807.47K–
Q1 FY2019Mar 31, 2019-$607.43K–
Q4 FY2018Dec 31, 2018-$463.98K–
Q3 FY2018Sep 30, 2018-$1.01M–
Q2 FY2018Jun 30, 2018-$1.16M–
Q1 FY2018Mar 31, 2018-$1.07M-6487.5%
Q4 FY2017Dec 31, 2017-$675.79K–
Q1 FY2017Mar 31, 2017-$58.70K–
Q4 FY2016Dec 31, 2016-$2.12M–
Q3 FY2016Sep 30, 2016$16.74K–
Q2 FY2016Jun 30, 2016-$2.57K–
Q1 FY2016Mar 31, 2016-$50.37K–

More Processa Pharmaceuticals figures

See a number that looks wrong?